Ken Masuda
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- Cancer Research top 10%
Papers in
- Oncology 47
- Cancer Immunotherapy and Biomarkers 25
- Lung Cancer Research Studies 13
- Colorectal Cancer Treatments and Studies 12
-
- Lung Cancer Treatments and Mutations 37
- Lung Cancer Diagnosis and Treatment 11
- Gastric Cancer Management and Outcomes 4
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 4
- Co-authors
- Yataro Daigo (11 shared papers)Eiju Tsuchiya (8 shared papers)Gouji Toyokawa (5 shared papers)Hyun‐Soo Cho (5 shared papers)Yusuke Nakamura (5 shared papers)Bruce A.J. Ponder (5 shared papers)Ryuji Hamamoto (6 shared papers)Helen I. Field (5 shared papers)
- Journals
- Lung Cancer (4 papers)Journal of Clinical Oncology (4 papers)Journal of Thoracic Oncology (3 papers)Nature Communications (3 papers)Clinical Lung Cancer (3 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Ken Masuda
74 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 133
- Oncology 716
- Cancer Research 242
- Pulmonary and Respiratory Medicine 487
- Molecular Biology 931
- Immunology 266
Countries citing papers authored by Ken Masuda
This map shows the geographic impact of Ken Masuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Masuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Masuda more than expected).
Fields of papers citing papers by Ken Masuda
This network shows the impact of papers produced by Ken Masuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Masuda. The network helps show where Ken Masuda may publish in the future.
Co-authors
The 25 scholars most cited alongside Ken Masuda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 211 | |
| 2 | 2011 | 158 | |
| 3 | 2010 | 129 | |
| 4 | 2012 | 124 | |
| 5 | 2019 | 119 | |
| 6 | 2009 | 113 | |
| 7 | 2012 | 98 | |
| 8 | 2011 | 96 | |
| 9 | 2022 | 90 | |
| 10 | 2011 | 84 | |
| 11 | 2011 | 76 | |
| 12 | 2020 | 53 | |
| 13 | 2011 | 45 | |
| 14 | 2022 | 33 | |
| 15 | 2011 | 23 | |
| 16 | 2021 | 22 | |
| 17 | 2011 | 21 | |
| 18 | 2021 | 21 | |
| 19 | 2000 | 19 | |
| 20 | 2010 | 19 |
About Ken Masuda
Ken Masuda is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Surgery and Epidemiology, having authored 79 papers that have together received 1.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (37 papers), Cancer Immunotherapy and Biomarkers (25 papers), Lung Cancer Research Studies (13 papers), Colorectal Cancer Treatments and Studies (12 papers), Lung Cancer Diagnosis and Treatment (11 papers), Cancer-related gene regulation (4 papers), Gastric Cancer Management and Outcomes (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). The work is most often cited by research in Oncology (716 citations), Cancer Research (242 citations), Pulmonary and Respiratory Medicine (487 citations), Molecular Biology (931 citations) and Immunology (266 citations). Ken Masuda has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Yataro Daigo, Eiju Tsuchiya, Gouji Toyokawa, Hyun‐Soo Cho, Yusuke Nakamura, Bruce A.J. Ponder, Ryuji Hamamoto, Helen I. Field, Nobuoki Kohno and Atsushi Takano. Their work appears in journals such as Lung Cancer, Journal of Clinical Oncology, Journal of Thoracic Oncology, Nature Communications and Clinical Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.